Supreme Court of Canada grants leave to appeal methods of medical treatment patentability decision
Federal Court addresses treatment and formulation patent claims in PMNOC case
Federal Court of Appeal clarifies law on patentability of methods of medical treatment
Federal Court of Appeal clarifies scope of implied licence on sale of patented medicine
Federal Court of Appeal Decides Case Splitting through NOAs is an Abuse of Process
Pharma in Brief’s 2023 Year in Review and Trends for 2024
Federal Court: Transferring drug submission does not require re-serving Notice of Allegation
Guidance on inventor discovery and “invention story” evidence in Canadian patent actions: Federal Court rules in favour of patentee
FCA upholds selection patent protecting apixaban and rejects that a second patented invention was obvious to try
Subscribe: Subscribe via RSS
Blogs
Firm/Org